Clinical trial
Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes
NCT01647308
Study timeline
Study start (unknown)2012-07-01Date precision: month
Registry last updated2022-01-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
ISIS-APOCIIIRXDRUG
PlaceboDRUG
Sponsors & collaborators
Ionis Pharmaceuticals, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01647308 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.